These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 14234753)

  • 61. Predicting plutonium decorporation efficacy after intravenous administration of DTPA formulations: Study of pharmacokinetic-pharmacodynamic relationships in rats.
    Phan G; Le Gall B; Deverre JR; Fattal E; Bénech H
    Pharm Res; 2006 Sep; 23(9):2030-5. PubMed ID: 16951998
    [TBL] [Abstract][Full Text] [Related]  

  • 62. An examination of some complexing agents for ability to remove intracellularly deposited plutonium.
    Bulman RA; Griffin RJ; Russell AT
    Health Phys; 1979 Dec; 37(6):729-34. PubMed ID: 544558
    [No Abstract]   [Full Text] [Related]  

  • 63. The effect of chemical form on the clearance of 239-plutonium from the respiratory system of the rat.
    Stather JW; Howden S
    Health Phys; 1975 Jan; 28(1):29-39. PubMed ID: 234116
    [No Abstract]   [Full Text] [Related]  

  • 64. METABOLISM OF SCANDIUM-46 IN MAN.
    ROSOFF B; SPENCER H; COHN SH; GUSMANO EA
    Int J Appl Radiat Isot; 1965 Aug; 16():479-85. PubMed ID: 14342013
    [No Abstract]   [Full Text] [Related]  

  • 65. The effect of pure LICAM(C) on the retention of plutonium-238 in mice and rats.
    Volf V; Taylor DM; Brandau W; Schlenker P
    Int J Radiat Biol Relat Stud Phys Chem Med; 1986 Aug; 50(2):205-11. PubMed ID: 3488281
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Whole-body distribution of plutonium in rats for different routes of exposure.
    Weber W; Doyle-Eisele M; Melo DR; Guilmette RA
    Int J Radiat Biol; 2014 Nov; 90(11):1011-8. PubMed ID: 24552148
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effectiveness of early DTPA treatments in two types of plutonium exposures in humans.
    Lagerquist CR; Hammond SE; Putzier EA; Piltingsrud CW
    Health Phys; 1965 Nov; 11(11):1177-80. PubMed ID: 5867870
    [No Abstract]   [Full Text] [Related]  

  • 68. [Determination of the plutonium-239 content of the body].
    Shvydko NS; Ivanova NP; Pushonik SI
    Radiobiologiia; 1988; 28(4):545-8. PubMed ID: 3420230
    [TBL] [Abstract][Full Text] [Related]  

  • 69. METABOLISM OF INSECTICIDES. 8. (1): EXCRETION, DISTRIBUTION AND METABOLISM OF ALPHA-CHLORDAN-14C BY RATS.
    POONAWALLA NH; KORTE F
    Life Sci (1962); 1964 Dec; 3():1497-500. PubMed ID: 14248643
    [No Abstract]   [Full Text] [Related]  

  • 70. Pharmacokinetics of DTPA entrapped in conventional and long-circulating liposomes of different size for plutonium decorporation.
    Phan G; Herbet A; Cholet S; Benech H; Deverre JR; Fattal E
    J Control Release; 2005 Dec; 110(1):177-88. PubMed ID: 16257469
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Second-order Kinetics of DTPA and Plutonium in Rat Plasma.
    Miller G; Poudel D; Klumpp JA; Guilmette RA; Melo D
    Radiat Res; 2018 Jan; 189(1):64-67. PubMed ID: 29140164
    [TBL] [Abstract][Full Text] [Related]  

  • 72. EFFECT OF TWO CHELATING AGENTS ON THE DISTRIBUTION AND EXCRETION OF LEAD.
    ARONSON AL; HAMMOND PB
    J Pharmacol Exp Ther; 1964 Nov; 146():241-51. PubMed ID: 14236936
    [No Abstract]   [Full Text] [Related]  

  • 73. Whole-body autoradiographic studies on plutonium metabolism as affected by its physico-chemical state and route of administration.
    Matsuoka O; Kashima M; Joshima H; Noda Y
    Health Phys; 1972 Jun; 22(6):713-22. PubMed ID: 5084002
    [No Abstract]   [Full Text] [Related]  

  • 74. Removal of internally deposited transuranium elements by Zn-DTPA.
    Seidel A; Volf V
    Health Phys; 1972 Jun; 22(6):779-83. PubMed ID: 5084010
    [No Abstract]   [Full Text] [Related]  

  • 75. DISTRIBUTION AND EXCRETION OF POLONIUM-210. I. COMPARISON OF ORAL AND INTRAVENOUS ROUTES IN THE RAT.
    STANNARD JN
    Radiat Res; 1964; Suppl 5():SUPPL 5:49-59. PubMed ID: 14215678
    [No Abstract]   [Full Text] [Related]  

  • 76. [TOXICITY, ELIMINATION AND TISSUE DISTRIBUTION OF DTPA-FE-59 IN RATS].
    CHIADOT P; BRENOT A; RINALDI R
    Pathol Biol; 1964 May; 12():583-8. PubMed ID: 14180961
    [No Abstract]   [Full Text] [Related]  

  • 77. The effect of combination of chelating agents on the translocation of intramuscularly depostied 239Pu nitrate in the rat.
    Volf V
    Health Phys; 1975 Jul; 29(1):61-8. PubMed ID: 1150463
    [No Abstract]   [Full Text] [Related]  

  • 78. In vitro and in vivo assessment of plutonium speciation and decorporation in blood and target retention tissues after a systemic contamination followed by an early treatment with DTPA.
    Sérandour AL; Grémy O; Fréchou M; Renault D; Poncy JL; Fritsch P
    Radiat Res; 2008 Aug; 170(2):208-15. PubMed ID: 18666819
    [TBL] [Abstract][Full Text] [Related]  

  • 79. EFFECTS OF PLUTONIUM IN SWINE SKIN AND ITS REMOVAL.HW-80500.
    MCCLANAHAN BJ; WOOD DH; HORSTMAN VG; RAGAN HA; BUSTAD LK
    HW SA US At Energy Comm; 1964 Jan; 18():120-2. PubMed ID: 24547208
    [No Abstract]   [Full Text] [Related]  

  • 80. Decorporation Approach after Rat Lung Contamination with Plutonium: Evaluation of the Key Parameters Influencing the Efficacy of a Protracted Chelation Treatment.
    Grémy O; Coudert S; Renault D; Miccoli L
    Radiat Res; 2017 Nov; 188(5):552-561. PubMed ID: 28945525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.